Prenetics' IM8 Signs Diplo as Global Ambassador and Equity Shareholder
PRE sits 42% above its 52-week low of $11.365 on light trading volume (0.4× avg).
Summary
Prenetics' IM8 named DJ and producer Diplo as a Global Ambassador and Prenetics shareholder in a multi-year partnership, its first ambassador from music. The release also restates IM8's growth metrics and 2026-2027 revenue guidance.
Key Events · M&A and Partnerships · PRE
-
Diplo Joins as IM8 Global Ambassador
Three-time GRAMMY winner Diplo becomes IM8's first ambassador from music and a Prenetics shareholder under a multi-year global partnership announced November 16, 2026.
-
Reach Extends Beyond Sport
Diplo brings more than 12 million followers across Instagram, TikTok and YouTube and more than 40 million monthly Spotify listeners, plus integration into Diplo's Run Club's remaining North American stops in San Diego (November 21, 2026) and Phoenix (January 23, 2027).
-
No Deal Economics Disclosed
The release gives no contract value, royalty rate or equity amount for the partnership; compensation is equity in Prenetics, consistent with the existing ambassador roster.
-
IM8 Momentum Restated
IM8 posted $45 million of Q2 2026 revenue, up approximately 359% year over year, and $20.9 million in July 2026 revenue, an annualized run-rate of approximately $251 million; full-year 2026 guidance is $220 million to $230 million with 2027 IM8 guidance of $400 million or more.
Analysis · PRE · Life Sciences
IM8 has added its first music ambassador, extending a roster built on elite athletes into an audience of 12M+ followers and 40M+ monthly listeners — the broadest cultural channel the brand has entered. As with prior ambassadors, Diplo takes equity rather than a spokesperson fee, so the deal is alignment-heavy and cash-light. The press release also restates IM8's momentum: $45M of Q2 2026 revenue (up ~359% year over year), a $20.9M July 2026 month (~$251M annualized run-rate), and full-year 2026 guidance of $220M-$230M with 2027 IM8 guidance of $400M or more. No financial terms of the partnership were disclosed, so the market impact rests on brand reach rather than contracted dollars.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PRE was trading at $16.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $272.5M. The 52-week trading range was $11.37 to $27.24. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.